Annie Burden

1.2k total citations · 1 hit paper
26 papers, 603 citations indexed

About

Annie Burden is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Annie Burden has authored 26 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 17 papers in Pulmonary and Respiratory Medicine and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Annie Burden's work include Asthma and respiratory diseases (22 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers) and Inhalation and Respiratory Drug Delivery (10 papers). Annie Burden is often cited by papers focused on Asthma and respiratory diseases (22 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers) and Inhalation and Respiratory Drug Delivery (10 papers). Annie Burden collaborates with scholars based in United Kingdom, United States and Spain. Annie Burden's co-authors include David Price, Alison Chisholm, Julie von Ziegenweidt, Njira Lugogo, Esther García Gil, Elizabeth V. Hillyer, Mike Thomas, Timo Strandberg, Marcello Arca and José María Mostaza and has published in prestigious journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

Annie Burden

24 papers receiving 595 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study

2023 170 citations Kausik K. Ray, Aikaterini Bilitou et al. The Lancet Regional Health - Europe profile →

Peers

Countries citing papers authored by Annie Burden

Since Specialization

Citations

This map shows the geographic impact of Annie Burden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Burden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Burden more than expected).

Fields of papers citing papers by Annie Burden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Burden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Burden. The network helps show where Annie Burden may publish in the future.

Co-authorship network of co-authors of Annie Burden

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Burden. A scholar is included among the top collaborators of Annie Burden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Burden. Annie Burden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study breakdown → 2023 ·The Lancet Regional Health - Europe ·Kausik K. Ray, (unknown), Aikaterini Bilitou, (unknown), Annie Burden, Carlos Aguíar, Marcello Arca, Derek Connolly, Mats Eriksson, Jean Ferrières, Ulrich Laufs, José María Mostaza, David Nanchen, Ernst Rietzschel, Timo Strandberg, Hermann Toplak, Frank L.J. Visseren, Alberico L. Catapano	170
2	Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study 2022 ·European Respiratory Journal ·Andrew Menzies‐Gow, Mark Gurnell, Liam G. Heaney, Jonathan Corren, Elisabeth H. Bel, Jorge Máspero, Timothy Harrison, David J. Jackson, David Price, Njira Lugogo, James L. Kreindler, Annie Burden, (unknown), (unknown), Kelly Padilla, Ubaldo J. Martin, Esther García Gil, (unknown)	11
3	Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study 2021 ·The Lancet Respiratory Medicine ·Andrew Menzies‐Gow, Mark Gurnell, Liam G. Heaney, Jonathan Corren, Elisabeth H. Bel, Jorge Máspero, Timothy Harrison, David J. Jackson, David Price, Njira Lugogo, James L. Kreindler, Annie Burden, (unknown), Kelly Padilla, Ubaldo J. Martin, Esther García Gil	90
4	Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis 2021 ·Allergy ·Giorgio Walter Canonica, Tim Harrison, Pascal Chanez, Francesco Menzella, Renaud Louis, Borja G. Cosío, Njira Lugogo, Arjun Mohan, Annie Burden, Esther García Gil	44
5	Applying UK real-world primary care data to predict asthma attacks in 3776 well-characterised children: a retrospective cohort study 2018 ·npj Primary Care Respiratory Medicine ·Steve Turner, Clare Murray, Mike Thomas, Annie Burden, David Price	19
6	Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids 2017 ·PLoS ONE ·Samatha Sonnappa, Richard J. Martin, Elliot Israel, Dirkje S. Postma, Wim van Aalderen, Annie Burden, Omar S. Usmani, David Price, (unknown)	26
7	Initial step-up treatment changes in asthmatic children already prescribed inhaled corticosteroids: a historical cohort study 2015 ·npj Primary Care Respiratory Medicine ·Steve Turner, Kathryn Richardson, Annie Burden, Mike Thomas, Clare Murray, David Price	9
8	REG endpoint validation: Do SABA prescribing records reliably reflect patient-reported reliever use? 2014 ·European Respiratory Journal ·Richard J. Martin, Alexandra L. Dima, Annie Burden, Helen K. Reddel, Guy Brusselle, Nikolaos G. Papadopoulos, Janet T. Holbrook, Todor A. Popov, Gene Colice, Emílio Pizzichini, Julie von Ziegenweidt, Alison Chisholm, David Price	1
9	Predictors of BTS Step 3 paediatric asthma prescribing 2014 ·European Respiratory Journal ·Clare Murray, Steve Turner, Mike Thomas, Kathryn Richardson, Annie Burden, Daniel J. West, David Price	0
10	REG endpoint validation: Do database asthma control measures predict future risk? 2014 ·European Respiratory Journal ·Guy Brusselle, Richard J. Martin, Annie Burden, Alexandra L. Dima, Emílio Pizzichini, Janet T. Holbrook, Nikolaos G. Papadopoulos, Todor A. Popov, Gene Colice, Helen K. Reddel, Julie von Ziegenweidt, Alison Chisholm, David Price	1
11	Comparative effectiveness of paediatric asthma step-up options: Increasing ICS dose vs adding separate LABA 2014 ·European Respiratory Journal ·Clare Murray, Steve Turner, Mike Thomas, Kathryn Richardson, Annie Burden, Daniel J. West, David Price	0
12	Real-world effectiveness and cost-effectiveness of asthma step-up options: A UK comparison of extrafine hydrofluoroalkane-beclometasone and combination therapy 2013 ·European Respiratory Journal ·Elliot Israel, Gene Colice, Jonathan Grigg, Richard J. Martin, Wim van Aalderen, Paul Dorinsky, Dirkje S. Postma, Nicolás Roche, Annie Burden, Julie von Ziegenweidt, (unknown), Elizabeth V. Hillyer, Vicky Thomas, David Price	1
13	Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients 2013 ·Primary Care Respiratory Journal ·David Price, Iain Small, John Haughney, Dermot Ryan, Kevin Gruffydd‐Jones, Federico Lavorini, (unknown), Annie Burden, (unknown), Christine King, Alberto Papi	37
14	Real-life asthma impairment: SABA use depends on smoking phenotype 2013 ·European Respiratory Journal ·Richard J. Martin, David Price, Andrew McIvor, Gary Wong, Jerry A. Krishnan, Jonathan D. Campbell, Leif Bjermer, Marc Miravitlles, Alison Chisholm, Annie Burden	1
15	Inappropriate prescriptions following initial COPD diagnosis 2013 ·UCL Discovery (University College London) ·Rupert Jones, Nick Freemantle, Marc Miravitlles, (unknown), Kevin Gruffydd‐Jones, (unknown), Rebecca Stewart, Anna Rigazio, Annie Burden, David Price	4
16	Using fractional exhaled nitric oxide (FeNO) to diagnose steroid‐responsive disease and guide asthma management in routine care 2013 ·Clinical and Translational Allergy ·David Price, Dermot Ryan, Annie Burden, Julie von Ziegenweidt, (unknown), Daryl Freeman, Kevin Gruffydd‐Jones, (unknown), (unknown), Alison Chisholm, Mike Thomas	46
17	Effectiveness of Same Versus Mixed Asthma Inhaler Devices: A Retrospective Observational Study in Primary Care 2012 ·Allergy Asthma and Immunology Research ·David Price, Henry Chrystyn, Alan Kaplan, John Haughney, Miguel Román-Rodríguez, Annie Burden, Alison Chisholm, Elizabeth V. Hillyer, Julie von Ziegenweidt, (unknown), Thys van der Molen	53
18	Missed opportunities to diagnose COPD 2011 ·European Respiratory Journal ·David A. Price, David Halpin, Robert J. Winter, Susan L. Hill, Eric Bateman, Daryl Freeman, Dermot Ryan, (unknown), (unknown), Annie Burden, Julie von Ziegenweidt, (unknown), Alison Chisholm, Rupert Jones	1
19	Device type and real-world effectiveness of asthma combination therapy: An observational study 2011 ·Respiratory Medicine ·David Price, Nicolás Roche, J. Christian Virchow, Annie Burden, (unknown), Alison Chisholm, Amanda Lee, Elizabeth V. Hillyer, Julie von Ziegenweidt	58
20	Contact hypersensitivity to azathioprine 1992 ·Contact Dermatitis ·Annie Burden, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact